Keysight Technologies Set to Join S&P 500; Ligand Pharmaceuticals to Join S&P MidCap 400; Marcus & Millichap and Arcosa to Join S&P SmallCap 600

Stock Information for Cato Corporation (The) Class A

Loading

Please wait while we load your information from QuoteMedia.